Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-va...
Leadership
Victor Perlroth M.D.Founder
Co-Founder, Chairman, CEO & President
John A. Borgeson CPA, M.B.A.
Executive VP, CFO & Secretary
Wayne To M.Phil.
Chief Technology Officer
Dolly S. Chang M.D., M.P.H., Ph.D.
Chief Scientific Officer
Hong Liang Ph.D.
Senior Vice President of Development
Stephen Raillard Ph.D.
Senior Vice President of Chemical Development & Manufacturing
Almas Qudrat M.Sc.
Chief Quality Officer
J. Pablo Velazquez-Martin M.D.
Chief Medical Officer
Laurent Ducay Ph.D.
Senior VP of Biologics Development & Manufacturing
